About Patrick Mooney
Patrick Mooney is CEO and director at Linnaeus Therapeutics.
Patrick Mooney reports to the SEC as a director or officer of 3 public companies: MetaStat (MTST), Echo Therapeutics (ECTE) and Quantrx Biomedical (QTXB.OB).
Patrick Mooney first appears on SEC filings in 2007.
Experience
This experience comes from Patrick Mooney's profile and from SEC filings. For roles taken from filings, the years are when the filings name Patrick Mooney in the role, so the role may have started earlier or lasted longer.
Linnaeus Therapeutics, Inc. Current
CEO and director
2016 – Present · Haddonfield, NJ
Develops experimental medicines for people with cancer.
MI
MetaStat, Inc.
Director
2012 – 2014 · Public company (MTST)
EI
Echo Therapeutics, Inc.
CEO and PRESIDENT, director
Chairman, President and CEO (2006 – 2013)
2006 – 2013 · Public company (ECTE)
QC
Quantrx Biomedical Corp.
Director
2010 · Public company (QTXB.OB)
AC
Aphton Corporation
Chairman, President and CEO
2004 – 2006
TP
Thomas Weisel Partners
Senior Biotechnology Analyst
2001 – 2003
Key Colleagues at Startups
The people Patrick Mooney works with at each company, as listed on that company's latest Form D.
Linnaeus Therapeutics, Inc. · Form D/A, Apr 2, 2026
JD
James Demetriades
Director
CA
Chris Arendt
Director
TT
Todd Thomson
Director
JL
John Lepping
Director
MP
Michael Poisel
Director